Alastair D. G. Lawson
UCB Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Immune Cell Function and Interaction, Protein purification and stability, Click Chemistry and Applications
Most-Cited Works
- → Rings in Drugs(2014)2,379 cited
- → Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product(1998)537 cited
- → Activation of Resting Human Primary T Cells with Chimeric Receptors: Costimulation from CD28, Inducible Costimulator, CD134, and CD137 in Series with Signals from the TCRζ Chain(2004)452 cited
- → Rings in Clinical Trials and Drugs: Present and Future(2022)393 cited
- → Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation(2017)251 cited
- → Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F(2020)182 cited
- → Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein–Protein Interactions (PPIs) through Stabilization of Desired Conformers(2017)142 cited
- → Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors(2010)126 cited
- → Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer(2019)124 cited
- → Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3(1994)122 cited